The Patent Finder

Biochem Pharma Inc.

Also on record
Records under this name other than patents Biochem Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Biochem Pharma Inc.

PatentTitleStatus Expires Confidence
US 7,914,794Novel Group B Streptococcus Antigens
Formerly held
Term ended
Term ended Jan 3, 2025 · Medium confidence
Term endedTerm ended Jan 3, 2025Medium confidence
US 7,119,202Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties
Formerly held
Term ended
Term ended Oct 10, 2023 · From the USPTO record
Term endedTerm ended Oct 10, 2023From the USPTO record
US 6,541,625Stereoselective synthesis of nucleoside analogues
Term ended
Term ended Feb 9, 2021 · From the USPTO record
Term endedTerm ended Feb 9, 2021From the USPTO record
US 6,743,910Stereoselective synthesis of nucleoside analogues
Term ended
Term ended Feb 9, 2021 · From the USPTO record
Term endedTerm ended Feb 9, 2021From the USPTO record
US 6,630,480Methods of treating leukemia
Formerly held
Term ended
Term ended Mar 28, 2020 · From the USPTO record
Term endedTerm ended Mar 28, 2020From the USPTO record
US 6,747,036Methods of Treating Leukemia
Formerly held
Term ended
Term ended Mar 28, 2020 · Medium confidence
Term endedTerm ended Mar 28, 2020Medium confidence
US 7,128,918Streptococcus antigens
Formerly held
Term ended
Term ended Dec 23, 2019 · From the USPTO record
Term endedTerm ended Dec 23, 2019From the USPTO record
US 6,069,250Method and compositions for the synthesis of dioxolane nucleosides with .beta.-configuration
Term ended
Term ended Feb 17, 2019 · From the USPTO record
Term endedTerm ended Feb 17, 2019From the USPTO record
US 8,829,030Compounds and Methods for the Treatment or Prevention of Flavivirus Infections
Formerly held
Lapsed on the fee record
Ended Sep 9, 2018 · High confidence
Lapsed on the fee recordEnded Sep 9, 2018High confidence
US 7,709,642Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
Lapsed on the fee record
Ended May 4, 2018 · From the USPTO record
Lapsed on the fee recordEnded May 4, 2018From the USPTO record
10 of 98 patents shown.
Pro members see all 98.
Pro members: see all 98 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited